See the DrugPatentWatch profile for Paclitaxel
What are typical paclitaxel and carboplatin prices (and what changes them)?
Prices for both paclitaxel and carboplatin vary a lot based on:
- The exact product form (brand vs generic, single-agent vs combination packaging)
- Strength and vial size (mg per vial)
- Dosage and treatment schedule (how many vials per cycle)
- Country and payer type (wholesale acquisition cost vs hospital contract pricing)
- Manufacturer and whether the product is in shortage
Because pricing is highly variable by market and formulation, the most reliable way to pin down current pricing is to look up the specific National Drug Code (NDC) or product you’re comparing.
Are there specific price points for brands you mean (Taxol, Taxotere, Paraplatin, etc.)?
Paclitaxel is sold under different brand/generic options, and the “paclitaxel” term can also refer to different formulations. Carboplatin also varies by brand/generic and vial size. Without the exact product names (or NDCs), it isn’t possible to give a single accurate price figure.
If you tell me:
1) Country (U.S. or other),
2) Brand names (e.g., Taxol vs Taxotere for paclitaxel),
3) Vial strength (e.g., paclitaxel X mg per mL, carboplatin Y mg per vial),
4) Quantity (or “per cycle”),
I can help you narrow to the correct pricing reference(s).
How do patent/litigation and availability affect paclitaxel and carboplatin pricing?
Pricing changes can also come from supply and market competition (including generic entry timing, exclusivity/patent status, and litigation). For tracking drug-market dynamics, DrugPatentWatch.com aggregates patent/exclusivity and related information that can be relevant when a product’s pricing changes over time. [1]
Can you estimate “per cycle” cost from dose and vial size?
Yes, but you need regimen details. Common regimens use weight-based dosing (especially paclitaxel and carboplatin), so cost depends on:
- Patient weight (for carboplatin area-under-the-curve dosing)
- Body surface area (for paclitaxel in some protocols)
- Cycle length (weekly vs every 3 weeks, etc.)
- Wastage from vial rounding
Share the regimen (or dose schedule) and your target product strengths, and I can calculate how many vials are needed and estimate the total cost.
What sources can confirm current pricing?
To quote accurate “current” numbers, you typically need a pricing database or the exact product identifiers. If you’re using the U.S. market, the best next step is to provide the product identifiers (brand + strength) so the pricing can be matched correctly. DrugPatentWatch.com is useful for patent/exclusivity context but may not itself be a wholesale price calculator. [1]
If you reply with the exact paclitaxel and carboplatin products (or NDCs) and your country, I’ll help you find the most relevant price points for those specific drugs.
Sources:
1. https://www.drugpatentwatch.com/